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Purpose: This study aimed to evaluate the ultrasonographic findings for various types of vascular 
closure devices (VCDs) immediately after the angiographic procedure and at 6-month follow-up.
Methods: We included 18 VCDs including Angio-Seal (n=4), FemoSeal (n=8), ExoSeal (n=3), 
Perclose (n=2), and StarClose (n=1) in this study. Four patients were implanted with 2 VCDs at 
the each side of bilateral femoral arteries, while the remaining 8 patients were inserted 1 VCD 
at the right femoral artery. Ultrasonography was performed within 10 days and at approximately 
6 months after the angiographic procedure. Ultrasonographic morphology of the attached VCD 
and its relationship with the arterial wall were analyzed.
Results: Initial ultrasonography revealed the attached VCD as the relevant unique structure 
with successful deployment and hemostasis. Follow-up ultrasonography demonstrated partial 
absorption of hemostatic materials in cases of Angio-Seal (n=3), FemoSeal (n=5), and ExoSeal 
(n=3), changes in the soft tissue surrounding the femoral artery in case of Angio-Seal (n=1), 
arterial intimal hyperplasia in cases of FemoSeal (n=3), and no gross changes as compared with 
the initial ultrasonographic findings in cases of Perclose (n=2) and StarClose (n=1).
Conclusion: Initial ultrasonographic evaluation reflected the unique structure of each VCD, with 
most of them being easily distinguishable. Follow-up ultrasonography revealed various changes 
in the affected vessels. 
Keywords: Vascular access devices; Hemostasis; Ultrasonography 
Introduction
With the evolution of medical technology, interventional radiology has become a key component 
of modern diagnostic and treatment methods [1]. In recent times, with increasing numbers of 
patients suffering from vascular diseases, the number of percutaneous endovascular procedures has 
correspondingly increased, with the majority of clinicians and patients preferring these less invasive Hye Jung Choo, et al.
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and less risky procedures over major surgery [2]. 
Hemostasis at the puncture site has a major impact on patient 
recovery and turnaround time. Manual compression has been 
widely used as an efficient tool for hemostasis. Vascular closure 
devices (VCDs) were developed in the 1990s as a faster and more 
convenient means of achieving hemostasis [1]. VCDs allow for the 
immediate closure of the arteriotomy site using various methods, 
such as collagen plugs, sutures, and clips. Sometimes, puncture 
sites are associated with certain complications, including simple 
hematoma, pseudoaneurysm, and distal ischemia [1]. Although VCDs 
are easy to use in the clinical setting, these associated complications 
are detected based on the patients’ subjective complaints; in the 
absence of such complaints, dangerous complications may remain 
undiagnosed. Therefore, the assessment of the puncture site 
following VCD deployment is essential in order to avoid overlooking 
any serious morbidity. 
Since the femoral artery is located superficially, it is easily 
accessible for ultrasonographic examination. Ultrasonography can 
identify vascular flow, which helps in confirming simple hematomas, 
pseudoaneurysms, and distal vascular poor runoff. Furthermore, 
ultrasonography provides a simple and convenient diagnostic 
approach that can be performed before patient ambulation. Until 
now, the ultrasonographic studies for various types of VCDs have 
been seldom reported. Without knowledge of the ultrasonographic 
findings of the VCDs, the normal VCDs can be misinterpreted 
as the complication during ultrasonographic exam. Vice versa, 
the associated complications with the applied VCDs can be 
misinterpreted as normal.
Therefore, this study aimed to demonstrate the in vivo ultrasono-
graphy findings for various types of VCDs and to compare the initial 
and follow-up ultrasonographic findings for each VCD. 
 
Materials and Methods
This study was approved by Inje University Busan Paik Hospital 
Institutional Review Board for human research. Informed consent 
was waived. From May 10, 2012, to June 25, 2012, 12 patients 
(1 male, 11 females; mean age, 56.3 years; range, 42 to 79 years) 
who admitted for neurovascular catheterization procedures and 
underwent femoral artery punctures were included in this study. 
None of them had any coagulation disorders. Overall, 16 VCDs were 
deployed in the 12 patients as follows: 8 patients received only 1 
VCD in the right femoral artery, while 2 VCDs were employed in the 
remaining 4 patients, with 1 VCD in the right and left femoral artery 
each. The applied VSDs were 5 to 6F in this study. 
Ultrasonographic studies, including gray-scale and color Doppler, 
were performed by 2 experienced radiologists using the iU22 model 
(Philips Medical Systems, Bothell, WA, USA) and a 5-12 MHz linear 
probe. Ultrasonographic findings for the VCD sites were initially 
investigated within 10 days after the angiographic procedure, 
and follow-up ultrasonography was performed at approximately 6 
months after the angiographic procedure. Ultrasonographic findings 
from the femoral puncture sites were evaluated for the identification 
of the structure changes of the deployed VCD, vascular patency, 
perivascular and overlying subcutaneous tissue change and the 
presence of complications.
In this study, 5 types of commercially available VCDs (Angio-Seal, 
St. Jude Medical, St. Paul, MN, USA; FemoSeal, St. Jude Medical; 
ExoSeal, Cordis Europe, Waterloo, Belgium; Perclose, Abbott Labs, 
Redwood City, CA, USA; and StarClose, Abbott Vascular, Santa 
Clara, CA, USA) were evaluated. The Angio-Seal group comprised 4 
cases; the FemoSeal group, 8 cases; the ExoSeal group, 3 cases; the 
Perclose group, 2 cases; and the StarClose group, 1 case.
Table 1. Follow-up periods and ultrasonographic findings of vascular closure devices
Interval between initial 
and F/U US
a)
Partial absorption of 
hemostatic material
Perivascular soft tissue 
change
b) Intimal hyperplasia
c) No interval change
d)
Angio-Seal (n=4) 182 (170-192) 3 1 0 0
FemoSeal (n=8) 175 (170-188) 5 0 3 0
ExoSeal (n=3) 184 (178-190) 3 0 0 0
Perclose (n=2) 184 (181-187) 0 0 0 2
StarClose (n=1) 188 (188) 0 0 0 1
Values are presented as mean (range) or number of cases.
F/U US, follow-up ultrasonography. 
a)Data are the number of date. 
b)Perivascular soft tissue change coexistent with partial absorption of hemostatic material. 
c)Intimal hyperplasia coexistent with partial absorption 
of hemostatic material. 
d)No interval change comparing to findings on initial ultrasonographic exam. US features of vascular closure devices
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Results
On initial ultrasonography, except for Perclose, each type of the 
attached VCDs was clearly visualized based on their unique 
structures; clustered hypoechoic lesions over the arterial wall, 
suggesting the collagen plug were observed in the Angio-Seal 
group; intra-arterial linear echogenicity, suggesting the intra-
arterial anchor plate in the FemoSeal group; extravascular tubular 
hypoechogenicity, suggesting the hematostatic plug in the ExoSeal 
group; very hyperechogenic line at the perivascular area, suggesting 
the metal clip in the StarClose group.  No major complications, such 
as inappropriate application of the VCD, unsatisfactory hemostasis, 
puncture site infection, or disruption of distal arterial flow, were 
observed.
Follow-up ultrasonograms demonstrated various changes as 
compared to the initial ultrasonogram; these were listed in Table 1. 
No adverse findings, such as femoral artery stenosis, were observed.
The Angio-Seal group (n=4) showed partial absorption of 
hemostatic material (clustered hypoechoic lesions over the arterial 
wall) in 3 cases (Fig. 1) and perivascular soft-tissue change in 1 
case. In the FemoSeal group (n=8), partial absorption of hemostatic 
material (intra-arterial linear echogenicity) was observed in 5 
cases and hypoechoic thickening of the arterial intima with partial 
absorption of hemostatic material was demonstrated in 3 cases 
(Fig. 2). The ExoSeal group (n=3) showed partial absorption of 
hemostatic material (extravascular tubular hypoechogenicity) 
in all the cases (Fig. 3). The Perclose group (n=2) and StarClose 
group (n=1) showed no changes as compared to the initial 
A B
Fig. 1. Angio-Seal closure device for a 66-year-old woman.
Photographies show Angio-Seal closure device (A) and its deployment into the silicone tube (B). Angio-Seal is composed of an intra-arterial 
anchor (arrowheads) and a small bovine collagen plug (arrow). After deployment, the anchor and collagen plug worked in tandem to 
compress the puncture site effectively. Initial longitudinal gray-scale ultrasonogram of the Angio-Seal deployed at the left femoral artery (C) 
shows a hypoechoic collagen plug (arrows) outside of the vessel wall. Follow-up ultrasonogram (D) reveals partial resorption of the collagen 
plug (arrow).
C DHye Jung Choo, et al.
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ultrasonographic findings (Figs. 4, 5).
 
Discussion
VCDs were introduced in the early 1990s as a method for 
hemostasis in order to reduce the procedure time, labor, bed rest 
period, and patient discomfort associated with manual compression. 
At present, two types of VCDs are available, i.e., active and passive. 
A passive VCD indirectly acts at the puncture site, utilizing an 
external patch or balloon coated with prothrombotic material. Thus, 
it does not achieve prompt hemostasis (<5 minutes) or shorten 
the time to ambulation. In contrast, an active VCD directly acts at 
the puncture site, utilizing suture devices, collagen plug devices, or 
clips [3]. In the present study, only active VCDs were used in all the 
enrolled patients, as described below.
The Angio-Seal is a bioabsorbable collagen closure device, 
composed of an intra-arterial anchor, small bovine collagen 
plug, and absorbable traction suture. The intra-arterial anchor is 
a T-shaped material composed of copolymers of polylactic and 
polyglycolic acids. The anchor and collagen plug are inserted into the 
femoral site; after deployment, the anchor and collagen plug work 
in tandem to compress the puncture site effectively. In the previous 
study using a porcine aorta, the collagen plug over the artery was 
identified on the ultrasonography [4]. Like that, clustered hypoechoic 
lesions above the arterial wall on initial ultrasonography of the 
present study may be the collagen plus, although the histologic 
confirmation about the lesion was not preformed. The hypoechoic 
lesions above the artery were not completely absorbed at 6 months 
of follow-up in all the cases of the present study. Further, the 
perivascular soft tissue change, manifested oval hypoechoic lesion 
A B
Fig. 2. FemoSeal closure device for a 55-year-old man.
Photographies show FemoSeal closure device (A) and its deployment into the silicone tube (B). FemoSeal comprises a relatively large 
bioabsorbable polymer anchor plate (arrowheads) and a relatively small outer disc (arrow). The anchor plate was deployed within the 
artery, while the outer locking disc was placed on the outer wall of the artery. Initial longitudinal gray-scale ultrasonogram of the FemoSeal 
deployed at the right femoral artery (C) reveals a linear-shaped echogenic anchor (arrows) at the intraluminal area of the femoral artery. 
Follow-up ultrasonogram (D) shows intimal hyperplasia with partial resorption of the anchor (arrows). 
C DUS features of vascular closure devices
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on ultrasonography was combined in one case. It can be postulated 
that tissue reaction was induced by the collagen plug, which may 
act as an obstacle in repuncturing the same femoral artery later.
The FemoSeal comprises a bioabsorbable polymer anchor plate 
and an outer disc. The anchor seal is deployed within the artery, 
while the outer locking disc is placed on the outer wall of the artery 
[5]. Initial ultrasonography of the applied FemoSeal successfully 
showed a linear echogenic intra-arterial lesion, which looked 
like the appearance of the bioabsorbable anchor plate. After 6 
months, the lesion regarded as the bioabsorbable materials had 
partially disappeared (8/8), while some of them (3/8) coexisted 
with hypoechoic thickening of the arterial intima. In the previous 
article [6], intimal hyperplasia occurred after vessel injury, which 
was manifested as the hypoechoic thickening of the arterial intima. 
Intimal hyperplasia is a physiologic response to injury to the blood 
vessel wall and results from vascular surgery and endovascular 
intervention. In the present study, the hypoechoic thickening of the 
intima may be an intimal hyperplasia and be caused by vessel wall 
reaction to the larger intra-arterial anchor plate. However, no serious 
luminal narrowing with intimal hyperplasia was observed in the 
present study.
The ExoSeal is advanced through a preexisting standard 
procedural sheath with an indicator wire loop deployed inside the 
artery. A tubular bioabsorbable plug is released on the surface 
of the vessel without an intra-arterial anchor [5]. On the initial 
ultrasonographic exam of this study, the tubular hypoechoic lesions 
at the extruluminal area of the femoral artery, which looked like the 
appearance of the bioabsorbable plug were demonstrated, and on 
A B
Fig. 3. ExoSeal closure device for a 43-year-old man.
Photographies show ExoSeal closure device (A) and its deployment into the silicone tube (B). ExoSeal is composed of a tubular bioabsorbable 
plug (arrow). The ExoSeal was advanced through a pre-existing standard procedural sheath with an indicator wire loop deployed inside the 
artery. The hemostatic bioabsorbable plug was released on the surface of the vessel without an intra-arterial anchor. Initial longitudinal gray-
scale ultrasonogram of the ExoSeal deployed at the right femoral artery (C) shows a hypoechoic extravascular hemostatic plug (arrows) 
outside of the femoral artery. Follow-up ultrasonogram (D) reveals partial resorption of the hemostatic plug (arrows).
C DHye Jung Choo, et al.
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the follow-up exam they were resorbed partially.
The Perclose device is a suture-mediated closure system. After 
positioning the device appropriately, a braided 3-0 polyester suture 
is deployed, and the device is removed after the knot has been 
tightened around the puncture site. These suture-attached needles 
puncture through the artery and are engaged by the barrel of the 
delivery system. Once engaged in the arterial wall, the sutures 
are manually tied in a conventional surgical slipknot, which is 
pushed down toward the surface of the arteriotomy to achieve 
suture-mediated closure [2]. In this study, the initial and follow-up 
ultrasonography showed no definite findings related to the VCD.
The StarClose device features a flexible nitinol clip measuring 4 
mm in diameter, which is designed to close femoral arteriotomies 
created by sheaths up to 6F in size. An implantable nitinol clip 
is engaged in the adventitial layer of the vessel, where its tines 
grasp the edges of arteriotomy and draw them together to close 
the puncture hole. In contrast to collagen-based devices, the 
nitinol clip used in the StarClose device is reported to have a low 
profile in bioreactivity and in inducing inflammatory soft tissue 
reaction [2]. A study involving the StarClose VCD has demonstrated 
the linear hyperechogenicity outside of the vascular wall on the 
ultrasonographic exam with no episodes of arterial or venous 
thrombosis or stenosis [7]. The present study also demonstrated 
the very hyperechoic line outside the vascular wall on the initial 
A B
Fig. 4. Perclose closure device for a 61-year-old woman.
Photographies show Perclose closure device (A) and its deployment into the fabric (B). The Perclose is a suture-mediated closure system. After 
positioning the device appropriately, a braided 3-0 polyester suture was deployed, and the device was removed after the knot (arrow) has 
been tightened around the puncture site. Initial longitudinal gray-scale ultrasonogram of the Perclose deployed at the right femoral artery (C) 
shows no definite abnormality except the very subtle perivascular hyperechogenicity (arrows). Follow-up ultrasonogram (D) demonstrates no 
findings inside and outside of the vessels. 
C DUS features of vascular closure devices
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hypoechogenicity in the ExoSeal group were interpreted as the 
hemostatic materials of the VCDs. It requires a further histologic 
study.
In conclusion, the initial ultrasonographic evaluation of each 
VCD reflected its unique structure, with most of them being easily 
distinguishable. In follow-up ultrasonography, various changes in 
the affected vessels were observed. These results are expected to 
be helpful to differentiate the normal VCD and complicated VCDs. 
Further studies may be required for evaluating the long-term 
outcomes for each VCD type.
ORCID: Hye Jung Choo: http://orcid.org/0000-0003-3941-6989; Hae Woong Jeong: 
ultrasonography for the StarClose VCD, which was not changed on 
follow-up ultrasonography. 
This study had limitations. First, the small number of patients 
was enrolled. Second, the number of each VCD was uneven. Third, 
the histologic confirmation about the ultrasonographic findings 
of VCDs was not performed. Moreover, there are few previous 
ultrasonographic or histologic studies about the VCDs except 
Angio-Seal and StarClose. Thus, there is little definite evidence 
to interpret the ultrasonographic findings. However, because the 
initial ultrasonographic appearance of each VCD was very similar to 
the unique structure of the each VCD, the findings of intra-arterial 
linear echogenicity in the FemoSeal group and extravascular tubular 
A B
Fig. 5. StarClose closure device for a 48-year-old woman.
Photographies show StarClose closure device (A) and its deployment into the fabric (B). The StarClose consists of a flexible nitinol clip 
measuring 4 mm in diameter (arrow), which was engaged in the adventitial layer of the vessel. Initial longitudinal gray-scale ultrasonogram 
of the StarClose deployed at the right femoral artery (C) shows a hyperechoic linear metal clip (arrow) at the extraluminal area of the right 
femoral artery. Follow-up ultrasonogram (D) reveals no specific change in the echogenic metal clip (arrow) at the femoral artery or the 
perivascular soft tissue. 
C DHye Jung Choo, et al.
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